Filing Details

Accession Number:
0001127602-19-003835
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-04 17:41:47
Reporting Period:
2019-01-31
Accepted Time:
2019-02-04 17:41:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1705843 Calyxt Inc. CLXT Agricultural Chemicals (2870) 271967997
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712191 F Daniel Voytas 2800 Mount Ridge Road
Roseville MN 55113
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-31 4,083 $3.71 97,065 No 4 M Direct
Common Stock Disposition 2019-01-31 4,083 $13.00 92,982 No 4 S Direct
Common Stock Acquisiton 2019-02-01 4,087 $3.71 97,069 No 4 M Direct
Common Stock Disposition 2019-02-01 4,087 $13.00 92,982 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-01-31 4,083 $0.00 4,083 $3.71
Common Stock Stock Option (Right to Buy) Disposition 2019-02-01 4,087 $0.00 4,087 $3.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,170 2024-12-03 No 4 M Direct
4,083 2024-12-03 No 4 M Direct
Footnotes
  1. Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
  3. The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering.